Skip to the main content.

2 min read

September 2024: BPI East

Join KBI Biopharma at BPI East

Booth # 319

When: 23-26 September, 2024

Where: Boston, Massachusetts

KBI Biopharma is headed to Boston, Massachusetts for BioProcess International (BPI) East this September! Don't miss our exciting events this year, including a Lunch & Learn and two presentations highlighting the innovations happening at KBI Biopharma. We look forward to connecting with industry leaders and showcasing our innovative, next-generation CDMO services.
Schedule a meeting >>

 

Featured Sessions

David and Derek-09-09 (1)

Join us for an insightful Lunch & Learn on "Amsphere A+: the Launch of a Highly Caustic Stable, High DBC Protein-A Affinity Resin." Protein A chromatography is a crucial step in the biomanufacturing of monoclonal antibodies, with numerous resin options available. In this session, we compare the characteristics and performance of several next-generation Protein A resins, including Amsphere A+ (JSR) and well-established alternatives like Amsphere A3 (JSR), Resin B, and Resin C. Our study evaluates dynamic binding capacity and post-capture product quality across IgG subclasses, highlighting Amsphere A+ as a top contender for high titer mAb processes.

Date: Tuesday, September 24
Time:
1:00 - 1:45 PM
Stream:
Scientific Lunch Presentation 4

LEARN MORE>>

David adn Derek-08 (1)

Discover how integrating automation with analytical data digitalization can accelerate process development in biomanufacturing. In the presentation "Acceleration of Process Development through Integration of Automation and Analytical Data Digitalization," we'll explore how high-throughput technologies and digitalization enable faster, more informed decision-making. By leveraging these advanced platforms, you'll see how generating higher volumes of data leads to a deeper understanding of processes and products, all while maintaining critical timelines.

Date: Tuesday, September 24
Time:
2:00 - 2:30 PM
Stream:
Analytical, Quality & Bioprocessing 4.0

LEARN MORE>>

Deanna Hunt graphic-07 (1)

Don't miss Deanna Hunt's presentation on the critical aspects of late-stage characterization for antibody-drug conjugates (ADCs) and their role in a robust analytical control strategy essential for successful marketing applications. This presentation emphasizes the essential role of comprehensive characterization in ensuring ADCs meet regulatory standards and therapeutic goals for patients with critical needs.

Date: Wednesday, September 25
Time:
2:10 - 2:30 PM
Stream:
Innovation and Community Stage (Exhibit Hall)

LEARN MORE>>

Meet with the KBI Biopharma Team:

Schedule a meeting >>

Sigma Mostafa Headshot

Sigma Mostafa

Chief Scientific Officer

Bio Link    Linkedin Icon
Debra Bruneau Headshot2

Debra Bruneau

Executive Vice President, Human Resources

   Linkedin Icon
 
Andrew Setikas-2

Andrew Setikas

Senior VP, Business Development
 
Bio Link    Linkedin Icon

 

Leslie Wolfe

Leslie Wolfe

VP of Process Development & Site Head
 
Bio Link    Linkedin Icon
 
 
KBI_PortraitTemplate_Deanna

DEANNA HUNT

Senior Director, Business Development

   Linkedin Icon
Derek Ryan

Derek Ryan

Senior Director, Analytical Development

   Linkedin Icon
 
KBI_PortraitTemplate_HenryJin2

Henry Jin

Director, Business Development

   Linkedin Icon
 

 

Isabell Choi

ISABELLA CHOI

Director, Business Development

   Linkedin Icon
 
Kierra Banks Headshot

Kierra Banks

Associate Director, Business Development

   Linkedin Icon
David Brown Headshot (1)

David Brown

Principal Scientist, Process Development

   Linkedin Icon
 
 
 

 

 
 

 

About KBI Biopharma: 

KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond. 

Learn more about KBI Biopharma >>

 

About the Event: 

Each year, more than 3200+ bioprocessing professionals representing 40+ countries attend BioProcess International to learn about today's innovative science across the entire spectrum of biopharmaceutical development and production. The exhibition has featured 250+ exhibitors showcasing novel technologies designed to accelerate biologics from process development through to commercial manufacturing.

 


Let's Connect

Interested in setting up a time to talk with our team of experts at this event? Looking to follow up on a recent tech talk, presentation, or booth conversation? Let us know! We'd love to hear from you! Fill out the form below and we will be in touch. 

 

December 2024: 3rd Annual Meeting of The Antibody Society of Japan

December 2024: 3rd Annual Meeting of The Antibody Society of Japan

Join KBI Biopharma at The 3rd Annual Meeting of the Antibody Society of Japan Booth # 3 When: December 9-11, 2024 Where: Sendai, Japan KBI Biopharma...

Read More
November 2024: PharmaLab 2024

November 2024: PharmaLab 2024

Join KBI Biopharma at PharmaLab 2024 When: November 25-27, 2024 Where: Düsseldorf, Germany KBI Biopharma is headed to Düsseldorf for PharmaLab 2024...

Read More
November 2024: Korea Life Science Week

November 2024: Korea Life Science Week

Join KBI Biopharma at Korea Life Science Week When: 12-14 November, 2024 Where: Seoul, Korea KBI Biopharma is headed to Seoul for Korea Life Science...

Read More